Gyre Therapeutics

GYRE

NASDAQHealth Care

Income Statement

Total Revenue$105.76M

Gross Profit$101.87M

Operating Income$16.1M

EBITDA$19.66M

EBIT$17.41M

Pre-tax Income$564K

Net Income$12.09M

Cash Equivalent$18.39M

Total Debt$1.41M

Book Value$94.75M

Book Value Per Share1.06

Return on Equity (ROE)+19.09%

Return on Assets (ROA)+9.64%

Return on Invested Capital (ROI)+19.09%

Net Profit Margin+11.43%

Current Ratio3.32

Quick Ratio2.93

Long-Term Debt / Equity0.00